(Stroke. 2000;31:1882.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Department of Primary Care and Population Sciences (S.G.W., A.G.S.), Royal Free and University College Medical School, and the Department of Social Medicine (S.E.), University of Bristol, Canynge Hall, Bristol, UK.
Correspondence to Dr S. Goya Wannamethee, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Rowland Hill St, London NW3 2PF, UK. E-mail goya{at}rfhsm.ac.uk
Background and PurposeThe purpose of this study was to examine the relation between serum HDL cholesterol and total cholesterol and risk of stroke.
MethodsWe carried out a prospective study in 7735 men, 40 to 59 years of age, drawn from 1 group practice in each of 24 British towns. Men with history of stroke were excluded (n=52).
ResultsDuring the mean follow-up period of 16.8 years, there
were 343 stroke cases (fatal and nonfatal) in the 7683 men with no
history of stroke. Higher levels of HDL cholesterol were
associated with a significant decrease in risk of stroke even after
adjustment for potential confounders (top fifth versus lowest fifth:
adjusted relative risk=0.68, 95% CI 0.46 to 0.99). The inverse
relation was seen only for nonfatal strokes (adjusted relative
risk=0.59, 95% CI 0.39 to 0.90; top fifth versus lowest fifth). Total
cholesterol showed no graded association with fatal
strokes, but men with levels
8.1 mmol/L (top 5% of the
distribution) showed increased risk of nonfatal stroke, although this
was not statistically significant after adjustment (adjusted RR=1.46,
95% CI 0.91 to 2.32). The beneficial effects of elevated HDL
cholesterol on nonfatal stroke were seen in both smokers
and nonsmokers and were more evident in men with hypertension than in
normotensives. In hypertensive men, elevated HDL
cholesterol (top fifth) was associated with a significant
50% reduction in risk of nonfatal strokes compared with men in the
lowest fifth.
ConclusionsHigher levels of HDL cholesterol were associated with a significant decrease in risk of nonfatal stroke. In contrast, elevated total cholesterol showed a weak positive association with nonfatal strokes. The marked inverse association between HDL cholesterol and stroke seen in hypertensives emphasizes the importance of those modifiable risk factors for stroke known to lower the concentrations of HDL cholesterol.
Key Words: cholesterol lipoproteins, HDL cholesterol stroke
This article has been cited by other articles:
![]() |
K Nakamura, F Barzi, R Huxley, T-H Lam, I Suh, J Woo, H C Kim, V L Feigin, D Gu, M Woodward, et al. Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases? Heart, June 1, 2009; 95(11): 909 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hyvarinen, Q. Qiao, J. Tuomilehto, T. Laatikainen, R. J. Heine, C. D.A. Stehouwer, K. G. M.M. Alberti, K. Pyorala, B. Zethelius, B. Stegmayr, et al. Hyperglycemia and Stroke Mortality: Comparison between fasting and 2-h glucose criteria Diabetes Care, February 1, 2009; 32(2): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imamura, Y. Doi, H. Arima, K. Yonemoto, J. Hata, M. Kubo, Y. Tanizaki, S. Ibayashi, M. Iida, and Y. Kiyohara LDL Cholesterol and the Development of Stroke Subtypes and Coronary Heart Disease in a General Japanese Population: The Hisayama Study Stroke, February 1, 2009; 40(2): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kushiro, K. Mizuno, N. Nakaya, Y. Ohashi, N. Tajima, T. Teramoto, S. Uchiyama, H. Nakamura, and for the Management of Elevated Cholesterol in the Pravastatin for Cardiovascular Event Primary Prevention in Patients With Mild-to-Moderate Hypertension in the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study Hypertension, February 1, 2009; 53(2): 135 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Woodward, F. Barzi, V. Feigin, D. Gu, R. Huxley, K. Nakamura, A. Patel, S. Ho, K. Jamrozik, and for the Asia Pacific Cohort Studies Collaboration Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region Eur. Heart J., November 1, 2007; 28(21): 2653 - 2660. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sanossian, J. L. Saver, M. Navab, and B. Ovbiagele High-Density Lipoprotein Cholesterol: An Emerging Target for Stroke Treatment Stroke, March 1, 2007; 38(3): 1104 - 1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurth, B. M. Everett, J. E. Buring, C. S. Kase, P. M. Ridker, and J. M. Gaziano Lipid levels and the risk of ischemic stroke in women Neurology, February 20, 2007; 68(8): 556 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ebrahim, J. Sung, Y.-M. Song, R. L Ferrer, D. A Lawlor, and G. D. Smith Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study BMJ, July 1, 2006; 333(7557): 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Circulation, June 20, 2006; 113(24): e873 - e923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Goldstein, R. Adams, M. J. Alberts, L. J. Appel, L. M. Brass, C. D. Bushnell, A. Culebras, T. J. DeGraba, P. B. Gorelick, J. R. Guyton, et al. Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke, June 1, 2006; 37(6): 1583 - 1633. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patel, M. Woodward, D. J. Campbell, D. R. Sullivan, S. Colman, J. Chalmers, B. Neal, and S. MacMahon Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease Eur. Heart J., September 2, 2005; 26(18): 1910 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Tirschwell, N. L. Smith, S. R. Heckbert, R. N. Lemaitre, W. T. Longstreth Jr., and B. M. Psaty Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups Neurology, November 23, 2004; 63(10): 1868 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
Asia Pacific Cohort Studies Collaboration Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region Circulation, October 26, 2004; 110(17): 2678 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Curb, R. D. Abbott, B. L. Rodriguez, K. H. Masaki, R. Chen, J. S. Popper, H. Petrovitch, G. W. Ross, I. J. Schatz, G. C. Belleau, et al. High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program Am. J. Epidemiol., July 15, 2004; 160(2): 150 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Bowman, H. D. Sesso, J. Ma, T. Kurth, C. S. Kase, M. J. Stampfer, and J. M. Gaziano Cholesterol and the Risk of Ischemic Stroke Stroke, December 1, 2003; 34(12): 2930 - 2934. [Abstract] [Full Text] [PDF] |
||||
![]() |
Asia Pacific Cohort Studies Collaboration Cholesterol, coronary heart disease, and stroke in the Asia Pacific region Int. J. Epidemiol., August 1, 2003; 32(4): 563 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Soyama, K. Miura, Y. Morikawa, M. Nishijo, Y. Nakanishi, Y. Naruse, S. Kagamimori, and H. Nakagawa High-Density Lipoprotein Cholesterol and Risk of Stroke in Japanese Men and Women: The Oyabe Study Stroke, April 1, 2003; 34(4): 863 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shahar, L. E. Chambless, W. D. Rosamond, L. L. Boland, C. M. Ballantyne, P. G. McGovern, and A. R. Sharrett Plasma Lipid Profile and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study Stroke, March 1, 2003; 34(3): 623 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kothari, R. J. Stevens, A. I. Adler, I. M. Stratton, S. E. Manley, H. A. Neil, and R. R. Holman UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine Stroke, July 1, 2002; 33(7): 1776 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Gorelick Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review Stroke, March 1, 2002; 33(3): 862 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Houterman, H.C. Boshuizen, W.M.M. Verschuren, S. Giampaoli, A. Nissinen, A. Menotti, and D. Kromhout Predicting cardiovascular risk in the elderly in different European countries Eur. Heart J., February 2, 2002; 23(4): 294 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rizos and D. P Mikhailidis Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention? Cardiovasc Res, November 1, 2001; 52(2): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mann, M. Skeaff, S. Truswell, F. B Hu, F. Sacks, W. C Willett, L. Hooper, C. D Summerbell, R. L Thompson, N. E Capps, et al. Dietary fats and prevention of cardiovascular disease BMJ, October 27, 2001; 323(7319): 1000 - 1000. [Full Text] |
||||
![]() |
H. Bloomfield Rubins, J. Davenport, V. Babikian, L. M. Brass, D. Collins, L. Wexler, S. Wagner, V. Papademetriou, G. Rutan, and S. J. Robins Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol : The Veterans Affairs HDL Intervention Trial (VA-HIT) Circulation, June 12, 2001; 103(23): 2828 - 2833. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |